1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others)

In Situ Hybridization, HPV Testing, Circulating Tumor Cells and Flow Cytometry are important histology and cytology approaches to testing. In situ hybridization and more specifically fluorescent in situ hybridization (FISH) techniques use DNA probes to detect pathogens and molecular structures in cells. More recently flow cytometry techniques and other cell capture devices allow lab professionals to select targeted cells that can be further analyzed with PCR, sequencing and mass spectrometry.
The result so far has been gene patterns that help distinguish cell and tumor attributes that demonstrate the presence of disease as well as risk for disease progression and sensitivity to specific therapeutics. A growing population of cancer patients has increased the number of histology analyses performed.

This Kalorama report contains market sizes and forecasts for these technologies, identifies drivers and market trends, and identifies the competitive situation in the market. Kalorama's analysis is the result of detailed research into secondary literature and primary interviews to develop reliable business planning information for entrants or investors in this market. Over 25 Company profiles are included as part of the research in this report.

Table Of Contents

The Market for Molecular Histology and Cytology (HPV, in situ hybridization, CTCs, Others)
CHAPTER ONE: EXECUTIVE SUMMARY
Segments Covered
Advanced Technologies
Size and Growth in the Market
CHAPTER TWO: MARKET ANALYSIS
Market by Geographic Region
Sample Preparation
In Situ Hybridization
Fluorescence in situ Hybridization (FISH)
HPV Testing
Molecular HPV and Pap Smear
Circulating Tumor Cells
Veridex
Qiagen, Roche
CTC Market
Flow Cytometry
Pharmacodiagnostic Histology
CHAPTER THREE: COMPANY PROFILES
Abbott Diagnostics
Advanced Cell Diagnostics (ACD)
Amoy Diagnostics Co. Ltd.
Applied Spectral Imaging Inc. (ASI)
Beckman Coulter, Inc. / Danaher
Becton, Dickinson and Company (BD) Franklin Lakes, NJ www.bd.com
BioView Ltd.
Circulomics Inc.
Covaris Inc.
Cymogen Dx, LLC
Dako A/S
Definiens
DxTerity Diagnostics Inc.
General Electric - GE Healthcare
Hologic, Inc.
HTG Molecular Diagnostics
Janssen Diagnostics
Kapa Biosystems Inc.
Leica Biosystems
PreTect AS (formerly Norchip)
QIAGEN N.V.
Roche Diagnostics
Sony Biotechnology ( iCyt )
Sysmex Corporation Kobe, Japan
Ventana Medical Systems Inc.


TABLE OF EXHIBITS
Figure 1-1: Market Trend by Type, 2015 and 2020 (in situ hybridization, HPV, Tissue
Microarrays, CTC, Flow Cytometry)
Table 2-1: Worldwide Molecular Histology/Cytology Sales, by Type, 2015 and 2020 (in situ
hybridization, HPV, Tissue Microarrays, CTC, Flow Cytometry)
Figure 2-1: Molecular Histology and Cytology Sales, 2015 and 2020
Figure 2-2: Worldwide Molecular Histology/Cytology Sales, by Region
(US, EU, Asia, ROW)
Table 2-2: Selected Molecular Histology Innovations, 2015
Table 2-3: Selected FFPE DNA/RNA Sample Preparation Innovations
Table 2-4: Selected Companies with in situ hybridization tests on the Market or
In Development for Cancer Diagnostics (Company, Comment, Market Status)
Figure 2-3: Pap and Molecular HPV Market Trend Compared
Table 2-5: Selected HPV Test Innovations
Table 2-6: Selected Innovations in CTC Technology
Table 2-7: Selected Companies Marketing Flow Cytometry Platforms or Consumables
Table 2-8: Major Pharmacodiagnostic Markers
Table 2-9: Selected Pharmacodiagnostic Histology Tests 33

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

2017-2021 World Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis--Supplier Shares, Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation

  • $ 9600
  • Industry report
  • January 2017
  • by Venture Planning Group

About this Report This report presents a detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are ...

2017-2021 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

2017-2021 Sexually-Transmitted Diseases (STD) Diagnostic Testing Market

  • $ 6200
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200. This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global s ...

2017-2021 World Sexually-Transmitted Diseases (STD) Market: Global Opportunities and Growth Strategies for Suppliers

2017-2021 World Sexually-Transmitted Diseases (STD) Market: Global Opportunities and Growth Strategies for Suppliers

  • $ 6200
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200. This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global s ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.